Drug profile · INN
migalastat
GALAFOLD
migalastat (GALAFOLD) is a alpha-galactosidase a stabiliser. Associated with AMICUS THERAPEUTICS PTY LTD.
EMA: approved TGA: approved Alimentary tract and metabolism (A16) A16AX
Patents linked 0
Pipeline programs 3
News articles 1
Drug details — migalastat
- Class
- Alimentary tract and metabolism (A16)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
migalastat (GALAFOLD) is a alpha-galactosidase a stabiliser. Associated with AMICUS THERAPEUTICS PTY LTD.
Key facts
INN migalastat
Brand GALAFOLD
Mechanism Alpha-galactosidase A stabiliser
Target Alpha-galactosidase A
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AX
Originator AMICUS THERAPEUTICS PTY LTD
Mechanism of action
Alpha-galactosidase A stabiliser
Primary target: Alpha-galactosidase A
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is migalastat?
migalastat (GALAFOLD) is a alpha-galactosidase a stabiliser. Associated with AMICUS THERAPEUTICS PTY LTD.
What is the brand name for migalastat?
GALAFOLD is a marketed brand name for migalastat. Check FDA Drugs@FDA for the current US label holder and prescribing information.